Compass Therapeutics, Inc. Common Stock (CMPX) is a publicly traded Healthcare sector company. As of September 22, 2026, CMPX trades at $1.30 with a market cap of $342.17M and a P/E ratio of -4.39. CMPX moved -24.45% today. Year to date, CMPX is -66.11%; over the trailing twelve months it is -46.31%. Its 52-week range spans $1.33 to $6.88. Analyst consensus is strong buy with an average price target of $9.33. Rallies surfaces CMPX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CMPX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.30 |
| Market Cap | $342.17M |
| P/E Ratio | -4.39 |
| EPS | $-0.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.88 |
| 52-Week Low | $1.33 |
| Volume | 11.36M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-66.49M |
| Gross Margin | 0.00% |
7 analysts cover CMPX: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.33.